HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Disclosure Of NDA Filings Recommended In Transparency Report

This article was originally published in The Tan Sheet

Executive Summary

Firms may have to marshal legal arguments to prevent public disclosure of drug development milestones, including OTC switch filings, following the FDA Transparency Task Force's recommendation that the agency disclose when applications are submitted and withdrawn

You may also be interested in...



FDA Unveils Plan To Boost Transparency To Industry

FDA has identified 19 steps to improve its communications with drug and medical device manufacturers, promising quicker responses to industry questions.

FDA Unveils Plan To Boost Transparency To Industry

FDA identified 19 steps to improve its communications with drug and medical device manufacturers, promising quicker responses to industry questions.

More FDA Transparency May Confuse Consumers, Stifle Competition - Industry

Some FDA proposals to increase transparency could threaten fair competition, innovation and firms' reputations unless the agency provides disclaimers and cautions consumers about drawing conclusions from the information

Related Content

Topics

UsernamePublicRestriction

Register

RS135300

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel